You have free access to this content

American Journal of Transplantation

Cover image for Vol. 8 Issue 1

January 2008

Volume 8, Issue 1

Pages 1–261

  1. Letter from the Editor

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. You have free access to this content
      Letter from the Editor (page 1)

      Philip F. Halloran

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02093.x

  2. The AJT Report

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. You have free access to this content
  3. Editorials

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. You have free access to this content
      High-Tech Detection of HLA Antibodies and Complement: Prospects and Limitations (pages 5–6)

      S. Schaub and J. C. Scornik

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02034.x

      Solid phase HLA antibody testing has improved patient monitoring before and after transplantation. Can this technology be expanded to measure complement activation and thus predict how much damage the antibody can do? See article by Bartel et al in this issue on page 41.

    2. You have free access to this content
      Jump-Starting Alloreactive T Cells With High-Activation Thresholds-Donor Langerhans Cells Provide the Charge (pages 7–8)

      R. L. Fairchild*

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02064.x

      Functional differences in dendritic cell populations may contribute to differences in immunogenicity of allogeneic tissues, and could contribute to improvements in vaccine therapy. See also article by Molinero et al in this issue on page 21.

  4. Minireviews

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. You have free access to this content
      Update on Immunizations in Solid Organ Transplant Recipients: What Clinicians Need to Know (pages 9–14)

      R. K. Avery and M. Michaels

      Version of Record online: 18 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02051.x

      Recently licensed vaccines and updated information on immunization strategies are discussed with regard to applications in transplant recipients.

    2. You have free access to this content
      Alemtuzumab (Campath-1H) in Kidney Transplantation (pages 15–20)

      G. Ciancio and G. W. Burke III

      Version of Record online: 18 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02053.x

      Although the original projections fell short for alemtuzumab utilization in kidney transplantation, protocol modifications have demonstrated promise that ultimately will require validation from long-term, randomized, prospective trials.

  5. Original Articles

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. Basic Science

      You have free access to this content
      Epidermal Langerhans Cells Promote Skin Allograft Rejection in Mice With NF-κB-impaired T Cells (pages 21–31)

      L. L. Molinero, P. Zhou, Y. Wang, H. Harlin, B. Kee, C. Abraham and M. L. Alegre

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02038.x

      • image
      • image
      • image
      • imageimage
      • image
      • image
      • image

      Donor Langerhans cells are necessary for rapid rejection of skin allografts by mice with selective T cell-impairment of NF-κB activation and are sufficient to promote rejection of cardiac allografts in these mice. See also editorial by Fairchild in this issue on page 7.

    2. You have free access to this content
      Expression of Complement Regulatory Proteins in Accommodated Xenografts Induced by Anti-α-Gal IgG1 in a Rat-to-Mouse Model (pages 32–40)

      J. Wen Ding, T. Zhou, L. Ma, D. Yin, J. Shen, C. P. Y. Ding, I. Y. Tang, G. W. Byrne and A. S. Chong

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02016.x

      • image
      • image
      • image
      • image
      • image
      • image

      The up-regulation of complement regulatory proteins, DAF, Crry and CD59, may abrogate complement-mediated rejection and permit the development of xenograft accommodation.

    3. Clinical Science

      You have free access to this content
      In Vitro Detection of C4d-Fixing HLA Alloantibodies: Associations With Capillary C4d Deposition in Kidney Allografts (pages 41–49)

      G. Bartel, M. Wahrmann, M. Exner, H. Regele, N. Huttary, M. Schillinger, G. F. Körmöczi, W. H. Hörl and G. A. Böhmig

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.01998.x

      • image
      • image
      • image

      This study demonstrates a high level of concordance between in vitro C4d fixation to FlowPRA beads and the finding of capillary C4d deposition in renal allografts, suggesting that, as an adjunct to conventional FlowPRA, [C4d]FlowPRA could provide a specific tool for monitoring of C4d positive antibody-mediated rejection. See also editorial by Schaub and Scornik in this issue on page 5.

    4. You have free access to this content
      Prospective Age-Matching in Elderly Kidney Transplant Recipients—A 5-Year Analysis of the Eurotransplant Senior Program (pages 50–57)

      U. Frei, J. Noeldeke, V. Machold-Fabrizii, H. Arbogast, R. Margreiter, L. Fricke, A. Voiculescu, V. Kliem, H. Ebel, U. Albert, K. Lopau, P. Schnuelle, B. Nonnast-Daniel, F. Pietruck, R. Offermann, G. Persijn and C. Bernasconi

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02014.x

      • image
      • image

      The age-matching allocation program of Eurotransplant has demonstrated in a 5 year analysis its ability to increase the number of available donors >65 yrs and to transplant these with reasonable success and shortened waiting time into recipients >65 yrs.

    5. You have free access to this content
      The Overlapping Risk Profile Between Dialysis Patients Listed and Not Listed for Renal Transplantation (pages 58–68)

      J. D. Schold, T. R. Srinivas, L. K. Kayler and H. U. Meier-Kriesche

      Version of Record online: 2 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02020.x

      • image
      • image
      • image
      • image

      Over the past decade, there has been a substantial overlap in the risk profile of ESRD patients listed and not listed for renal transplantation, with the number of patients not listed with good prognoses significantly exceeding the number of listed patients with poor prognoses.

    6. You have free access to this content
      Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation (pages 69–77)

      T. Reischig, P. Jindra, O. Hes, M. Švecová, J. Klaboch and V. Třeška

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02031.x

      • image
      • imageimageimage

      This randomized trial of valacyclovir prophylaxis versus preemptive valganciclovir therapy in renal transplant recipients showed that both approaches were equally effective in CMV disease prevention but higher incidence of biopsy-proven acute rejection with preemptive therapy was observed.

    7. You have free access to this content
      The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function (pages 78–85)

      T. F. Mueller, J. Reeve, G. S. Jhangri, M. Mengel, Z. Jacaj, L. Cairo, M. Obeidat, G. Todd, R. Moore, K. S. Famulski, J. Cruz, D. Wishart, C. Meng, B. Sis, K. Solez, B. Kaplan and P. F. Halloran

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02032.x

      • image
      • image

      The transcriptome of kidneys at the time of transplantation, assessed by microarrays, reflects kidney quality and susceptibility to delayed graft function better than available clinical and histopathologic scoring systems.

    8. You have free access to this content
      Analysis of Renal Transplant Protocol Biopsies in ABO-Incompatible Kidney Transplantation (pages 86–94)

      K. Setoguchi, H. Ishida, H. Shimmura, T. Shimizu, H. Shirakawa, K. Omoto, D. Toki, S. Iida, S. Setoguchi, T. Tokumoto, S. Horita, H. Nakayama, Y. Yamaguchi and K. Tanabe

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02036.x

      • image

      This study of protocol biopsies in ABO-incompatible transplant recipients, compared to those of ABO-compatible transplant recipients, showed an increased incidence of subclinical rejection at 6 to 12 months after transplantation and revealed that C4d deposition in the peritubular capillaries was more common.

    9. You have free access to this content
      Role of Minor Histocompatibility Antigens in Renal Transplantation (pages 95–102)

      A. Heinold, G. Opelz, S. Scherer, A. Ruhenstroth, G. Laux, B. Doehler and T. H. Tran

      Version of Record online: 18 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02042.x

      • image

      This study of 702 recipient/donor pairs found no statistically significant effect of disparities for minor histocompatibility antigens on kidney graft survival.

    10. You have free access to this content
      Proinflammatory CD14+CD16+ Monocytes Are Associated With Subclinical Atherosclerosis in Renal Transplant Patients (pages 103–110)

      C. Ulrich, G. H. Heine, M. K. Gerhart, H. Köhler and M. Girndt

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02035.x

      • imageimageimage
      • imageimage
      • imageimage

      The frequency of circulating CD14+CD16+ monocytes in blood correlates with carotid intima media thickness in renal transplant recipients independently from traditional cardiovascular risk factors.

    11. You have free access to this content
      HLA Class II-Like Antiidiotypic Antibodies from Highly Sensitized Patients Inhibit T-Cell Alloresponses (pages 111–120)

      N. Hack, S. Angra, T. McKnight, N. DenHollander and C. J. Cardella

      Version of Record online: 18 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02043.x

      • image
      • image
      • image
      • image
      • image
      • image

      The HLA class II-like anti-idiotypic IgG molecules that have been detected in the sera of highly sensitized patients correlate with the degree of allosensitization, bind to the TCR of CD4+ T cells, reduce T cell responses to alloantigens and may contribute to sustained allosensitization.

    12. You have free access to this content
      Immunodominance Hierarchies and Gender Bias in Direct TCD8-Cell Alloreactivity (pages 121–132)

      N. A. Mifsud, A. W. Purcell, W. Chen, R. Holdsworth, B. D. Tait and J. McCluskey

      Version of Record online: 18 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02044.x

      • imageimage
      • image
      • image
      • image
      • image
      • image

      Dissecting individual T cell allo-specificities in the context of multiple donor-responder differences in MHC-I reveals patterns of immunodominance that are gender-related and HLA allotype dependent.

    13. You have free access to this content
      Two Novel Assays of Alloantibody-Secreting Cells Demonstrating Resistance to Desensitization With IVIG and rATG (pages 133–143)

      D. K. Perry, H. S. Pollinger, J. M. Burns, D. Rea, E. Ramos, J. L. Platt, J. M. Gloor and M. D. Stegall

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02039.x

      • image
      • image
      • image
      • image
      • image
      • imageimage
      • image

      Using bone marrow derived CD138+ cells, two new asays measure the frequency and specificities of alloantibody secreting cells in sensitized patients and provide a means of assessing the efficacy of various agents in blocking antibody production.

    14. You have free access to this content
      Analysis of Subcutaneous (SQ) Alemtuzumab Induction Therapy in Highly Sensitized Patients Desensitized With IVIG and Rituximab (pages 144–149)

      A. A. Vo, E. A. Wechsler, J. Wang, A. Peng, M. Toyoda, M. Lukovsky, N. Reinsmoen and S. C. Jordan

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02017.x

      • image
      • image
      • image

      This study evaluating the use of alemtuzumab administered subcutaneously as induction therapy in highly HLA- sensitized patients desensitized with IVIG and rituximab suggests that subcutaneous administration is feasible.

    15. You have free access to this content
      Impaired Bone Health in Adolescents After Liver Transplantation (pages 150–157)

      H. Valta, H. Jalanko, C. Holmberg, I. Helenius and O. Mäkitie

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02015.x

      • image
      • image
      • image

      Adolescent liver transplant recipients are prone to osteoporosis, which may require specific targeted therapy for prevention.

    16. You have free access to this content
      A Survey of CMV Prevention Strategies After Liver Transplantation (pages 158–161)

      J. Levitsky, N. Singh, M. M. Wagener, V. Stosor, M. Abecassis and M. G. Ison

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02026.x

      This survey of U.S. liver transplant centers demonstrates the frequent use of cytomegalovirus prophylaxis over preemptive strategies, PCR for detection and management, and valganciclovir for prophylaxis and treatment of viremia.

    17. You have free access to this content
      Cystic Fibrosis Liver Disease: To Transplant or Not to Transplant? (pages 162–169)

      K.L. Nash, J.D. Collier, J. French, D. McKeon, A.E.S. Gimson, N.V. Jamieson, J. Wallwork, D. Bilton and G.J.M. Alexander

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02028.x

      • image
      • image
      • image
      • image

      Liver transplantation for cystic fibrosis liver disease in adults has a less favourable outcome than that reported for pediatric cohorts.

    18. You have free access to this content
      Impact of a Left-Lobe Graft Without Modulation of Portal Flow in Adult-to-Adult Living Donor Liver Transplantation (pages 170–174)

      N. Konishi, Y. Ishizaki, H. Sugo, J. Yoshimoto, K. Miwa and S. Kawasaki

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02037.x

      • image
      • image

      Although in adult-to-adult living donor liver transplantation, left- lobe grafts can sometimes be small-for-size, a graft volume-to- standard liver volume ratio of less than 40% or portal vein flow of more than 260 ml/min/100 g graft weight does not contraindicate transplantation, nor is it necessarily associated with a poor outcome.

    19. You have free access to this content
      Posttransplant Diabetes Mellitus After Pancreas Transplantation (pages 175–182)

      P. G. Dean, Y. C. Kudva, T. S. Larson, W. K. Kremers and M. D. Stegall

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02018.x

      • image
      • image
      • image

      Post-transplant diabetes mellitus is frequent following pancreas transplantation, associated with increased BMI, high pre-transplant insulin requirements, and rejection episodes.

    20. You have free access to this content
      Glucose-Stimulated Increment in Oxygen Consumption Rate as a Standardized Test of Human Islet Quality (pages 183–192)

      I. R. Sweet, M. Gilbert, S. Scott, I. Todorov, R. Jensen, I. Nair, I. Al-Abdullah, J. Rawson, F. Kandeel and K. Ferreri

      Version of Record online: 16 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02041.x

      • image
      • image
      • image
      • image
      • image
      • image

      Major requirements were met for an islet potency assay (islet specificity, reproducibility by different groups, predictive of transplant success in diabetic mice), laying the foundation for testing its use in assessing islet quality for human islet transplantation.

    21. You have free access to this content
      An Empirical Examination of the Antecedents of the Acceptance of Donation After Cardiac Death by Health Care Professionals (pages 193–200)

      A. M. D'Alessandro, J. W. Peltier and J. E. Phelps

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02019.x

      • image

      A Donation After Cardiac Death (DCD) acceptance model for increasing DCD support of health care professionals is conceptualized and validated. Implementation of these guidelines was associated in a 225% increase in DCD.

    22. You have free access to this content
      Twenty-Year Experience With Heart Transplantation for Infants and Children With Restrictive Cardiomyopathy: 1986–2006 (pages 201–207)

      A. J. Bograd, S. Mital, J. C. Schwarzenberger, R. S. Mosca, J. M. Quaegebeur, L. J. Addonizio, D. T. Hsu, J. M. Lamour and J. M. Chen

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02027.x

      • image
      • image

      Cardiac transplantation in pediatric patients with idiopathic restrictive cardiomyopathy may be a feasible option in those once precluded on the basis of elevated pulmonary vascular resistance index.

    23. You have free access to this content
      Multicenter Experience of ABO-Incompatible Pediatric Cardiac Transplantation (pages 208–215)

      S. L. Roche, M. Burch, J. O'Sullivan, J. Wallis, G. Parry, R. Kirk, M. Elliot, N. Shaw, J. Flett, J. R. L. Hamilton and A. Hasan

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02040.x

      • image
      • image
      • image
      • image

      In 21 children age 2-40 months in Britain who received ABO incompatible heart transplants, all are surviving with no antibody-mediated rejection, and 19/21 have no donor-specific isohemagglutinins.

      Corrected by:

      Erratum

      Vol. 8, Issue 6, 1354, Version of Record online: 29 APR 2008

  6. Brief Communication

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. You have free access to this content
      Successful Liver-Kidney Transplantation in Two Children With aHUS Caused by a Mutation in Complement Factor H (pages 216–221)

      H. Jalanko, S. Peltonen, A. Koskinen, J. Puntila, H. Isoniemi, C. Holmberg, A. Pinomäki, E. Armstrong, A. Koivusalo, E. Tukiainen, H. Mäkisalo, J. Saland, G. Remuzzi, S. De Cordoba, R. Lassila, S. Meri and T. S. Jokiranta

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02029.x

      • image
      • image
      • image
      • image

      A 12-month old boy and his 16-year old aunt developed atypical hemolytic uremic syndrome secondary to a mutation in complement factor H, and both were successfully treated with liver-kidney transplantation.

  7. Case Reports

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. You have free access to this content
      Rituximab Failed to Improve Nephrotic Syndrome in Renal Transplant Patients With Recurrent Focal Segmental Glomerulosclerosis (pages 222–227)

      J. M. Yabu, B. Ho, J. D. Scandling and F. Vincenti

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02021.x

      • imageimage

      Four adult renal transplant patients receiving their first transplant with relapsing recurrent FSGS failed to show remission of proteinuria after rituximab treatment alone.

    2. You have free access to this content
      Successful Treatment of Recurrent Henoch–Schönlein Purpura in a Renal Allograft with Plasmapheresis (pages 228–231)

      J. Lee, F. Clayton, F. Shihab and A. Goldfarb-Rumyantzev

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02022.x

      • image
      • image
      • image

      A 29-year old kidney allograft recipient with early recurrence of Henoch-Shonlein purpura responded to four cycles of plasmapheresis with loss of proteinuria and marked reduction in IgA deposition in her biopsy.

    3. You have free access to this content
      Mosaicism in Autosomal Dominant Polycystic Kidney Disease Revealed by Genetic Testing to Enable Living Related Renal Transplantation (pages 232–237)

      A. Connor, P. W. Lunt, C. Dolling, Y. Patel, A. L. Meredith, A. Gardner, N. K. Hamilton and C. R. K. Dudley

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02030.x

      • imageimageimage
      • image

      This case highlights the difficulties encountered when excluding ADPKD in young potential living-related kidney donors and provides the first description of mosaicism in ADPKD.

    4. You have free access to this content
      Transmission of Anaplastic Large Cell Lymphoma via Organ Donation After Cardiac Death (pages 238–244)

      J. W. Harbell, T. B. Dunn, M. Fauda, D. G. John, A. S. Goldenberg and L. W. Teperman

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02033.x

      • image
      • image
      • image
      • image

      Four recipients of solid organ transplants from a DCD donor who was later found to have anaplastic brain T cell lymphoma developed T cell lymphoma, and one died of the tumor despite therapy.

    5. You have free access to this content
      Hashimoto's Encephalopathy After Intensive Lymphocyte Depletion With Rabbit Anti-thymocyte Globulin in a Renal Transplant Patient (pages 245–249)

      R. B. Stevens, C. B. Wakefield, D. Alonso, J. Y. Skorupa, T. H. Rigley, D. M. Penn and L. E. Wrenshall

      Version of Record online: 18 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02050.x

      • image
      • image

      This patient receiving intensive rATG induction later presented with Hashimoto's encephalopathy (steroid-responsive associated with autoimmune thyroiditis) resulting in coma, possibly aggravated by a steroid-free immunosuppressive protocol.

    6. You have free access to this content
      Does the Permanent Portacaval Shunt for a Small-for-Size Graft in a Living Donor Liver Transplantation Do More Harm Than Good? (pages 250–252)

      T. Oura, M. Taniguchi, T. Shimamura, T. Suzuki, K. Yamashita, M. Uno, R. Goto, M. Watanabe, T. Kamiyama, M. Matsushita, H. Furukawa and S. Todo

      Version of Record online: 18 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02045.x

      • image
      • image

      Permanent portacaval shunt for a small-for-size graft in a living donor liver transplantation resulted in graft atrophy, which was reversed when the shunt was closed.

    7. You have free access to this content
      Posttransplant Epstein-Barr Virus-Associated Myogenic Tumors: Case Report and Review of the Literature (pages 253–258)

      B. Sprangers, S. Smets, X. Sagaert, A. Wozniak, E. Wollants, M. Van Ranst, M. Debiec-Rychter, R. Sciot, Y. Vanrenterghem and D. R. Kuypers

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1600-6143.2007.02054.x

      • image
      • image

      Epstein-Barr virus-associated myogenic tumors are a rare complication after transplantation. In this report, a case study is combined with a review of the literature to explore the pathophysiological mechanisms behind this intruiging entity.

  8. Special Feature

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. You have free access to this content
      In Memoriam—James S. Wolf (pages 259–260)

      T. E. Starzl and R. Shapiro

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.02025.x

      Dr. Wolf was a first generation kidney transplant surgeon who contributed to the development of transplantation in the United States, and later himself received a heart transplant.

  9. Erratum

    1. Top of page
    2. Letter from the Editor
    3. The AJT Report
    4. Editorials
    5. Minireviews
    6. Original Articles
    7. Brief Communication
    8. Case Reports
    9. Special Feature
    10. Erratum
    1. You have free access to this content
      Erratum (page 261)

      Version of Record online: 5 NOV 2007 | DOI: 10.1111/j.1600-6143.2007.01955.x

      This article corrects:

      Pneumonia After Lung Transplantation in the Resitra Cohort: A Multicenter Prospective Study

      Vol. 7, Issue 8, 1989–1996, Version of Record online: 5 JUL 2007

SEARCH

SEARCH BY CITATION